FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016952598> ?p ?o ?g. }

• W2016952598 endingPage "1560" @default.
• W2016952598 startingPage "1553" @default.
• W2016952598 abstract "The potential of antibodies raised against insulin-like growth factor-1 (IGF-1) as a treatment to enhance the anabolic actions of IGF-1 has been demonstrated in both rodent and ruminant models. We investigated whether treatment of genetically normal rats with anti-IGF-1 immunoglobulin (Ig, raised in cattle) would enhance growth and if anti-IGF-1 Ig treatment would ameliorate live-weight loss in genetically normal rats offered a severely protein-restricted diet. Scatchard analysis was used to characterise ammonium sulphate precipitated bovine anti-IGF-1 Ig. Anti-IGF-1 Ig binding to 125I-IGF-1 yielded an almost linear Scatchard plot, with a Hill co-efficient of 0.951 ± 0.012, indicating a single class of IGF-1 binding sites. The affinity of anti-IGF-1 Ig for IGF-1 was 2.14 ± 0.66 × 109 l/mol. The non-immune Ig preparation did not bind IGF-1. Rats were offered either a diet with a normal protein level (20%) or protein restricted (4% protein), and each dietary group was further treated with twice-daily i.p. injections of either diluent phosphate buffered saline, non-immune Ig or anti-IGF-1 Ig. Dietary protein level had a significant effect on live-weight gain, but there was no effect of non-immune Ig or anti-IGF-1 Ig on live-weight gain. Treatment with anti-IGF-1 Ig prevented the significant depression of cumulative dietary intake observed in diluent, and non-immune Ig treated groups offered the 4% protein diet. The cumulative dietary intake of the anti-IGF-1 Ig treated, 4% dietary protein group did not differ significantly from those of the groups offered the 20% protein diet. In addition, within the 4% dietary protein group, rats treated with non-immune Ig exhibited a cumulative feed intake that was intermediate between that of the diluent treated and anti-IGF-1 Ig treated groups (P < 0.05). Size exclusion chromatography was used to characterise in vitro 125I-IGF-1 binding in end-point plasma from each treatment group. In comparison to control groups, anti-IGF-1 Ig treatment resulted in substantially increased 125I-IGF-1 binding in the 30 to 40 kDa region and a concomitant reduction in elution of free 125I-IGF-1. Protein restriction markedly depressed IGF-1 binding at ∼150 kDa in the plasma of diluent and non-immune Ig treated groups. Anti-IGF-1 Ig treatment was effective in preventing this decrease in ∼150 kDa binding. Thus, anti-IGF-1 Ig appears to have a beneficial effect on dietary intake in protein-restricted rats, which is associated with induced changes in IGF-1 binding profiles in plasma." @default.
• W2016952598 created "2016-06-24" @default.
• W2016952598 creator A5015141622 @default.
• W2016952598 creator A5023630675 @default.
• W2016952598 creator A5043388995 @default.
• W2016952598 creator A5048991895 @default.
• W2016952598 date "2010-01-01" @default.
• W2016952598 modified "2023-10-18" @default.
• W2016952598 title "Administration of bovine anti-IGF-1 immunoglobulin to dietary protein deficient rats alters dietary intake and plasma IGF-1 binding profiles, but does not affect change in body mass" @default.
• W2016952598 cites W159198934 @default.
• W2016952598 cites W1964922651 @default.
• W2016952598 cites W1966857769 @default.
• W2016952598 cites W1968285698 @default.
• W2016952598 cites W1974921448 @default.
• W2016952598 cites W1994417722 @default.
• W2016952598 cites W2001117441 @default.
• W2016952598 cites W2004546786 @default.
• W2016952598 cites W2007665594 @default.
• W2016952598 cites W2011236151 @default.
• W2016952598 cites W2015153782 @default.
• W2016952598 cites W2020936520 @default.
• W2016952598 cites W2035285457 @default.
• W2016952598 cites W2042026913 @default.
• W2016952598 cites W2042709015 @default.
• W2016952598 cites W2043813981 @default.
• W2016952598 cites W2063049842 @default.
• W2016952598 cites W2066114232 @default.
• W2016952598 cites W2072977857 @default.
• W2016952598 cites W2074136627 @default.
• W2016952598 cites W2078710800 @default.
• W2016952598 cites W2084765992 @default.
• W2016952598 cites W2089375920 @default.
• W2016952598 cites W2094821865 @default.
• W2016952598 cites W2105550333 @default.
• W2016952598 cites W2110003603 @default.
• W2016952598 cites W2128974599 @default.
• W2016952598 cites W2137313239 @default.
• W2016952598 cites W2145755665 @default.
• W2016952598 cites W2171190278 @default.
• W2016952598 cites W2272713137 @default.
• W2016952598 cites W2316474280 @default.
• W2016952598 doi "https://doi.org/10.1017/s1751731110000686" @default.
• W2016952598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22444703" @default.
• W2016952598 hasPublicationYear "2010" @default.
• W2016952598 type Work @default.
• W2016952598 sameAs 2016952598 @default.
• W2016952598 citedByCount "1" @default.
• W2016952598 countsByYear W20169525982013 @default.
• W2016952598 crossrefType "journal-article" @default.
• W2016952598 hasAuthorship W2016952598A5015141622 @default.
• W2016952598 hasAuthorship W2016952598A5023630675 @default.
• W2016952598 hasAuthorship W2016952598A5043388995 @default.
• W2016952598 hasAuthorship W2016952598A5048991895 @default.
• W2016952598 hasBestOaLocation W20169525981 @default.
• W2016952598 hasConcept C1008401 @default.
• W2016952598 hasConcept C126322002 @default.
• W2016952598 hasConcept C134018914 @default.
• W2016952598 hasConcept C159654299 @default.
• W2016952598 hasConcept C170493617 @default.
• W2016952598 hasConcept C185592680 @default.
• W2016952598 hasConcept C203014093 @default.
• W2016952598 hasConcept C2775960820 @default.
• W2016952598 hasConcept C2780689927 @default.
• W2016952598 hasConcept C2780898057 @default.
• W2016952598 hasConcept C71924100 @default.
• W2016952598 hasConcept C86803240 @default.
• W2016952598 hasConcept C8891405 @default.
• W2016952598 hasConceptScore W2016952598C1008401 @default.
• W2016952598 hasConceptScore W2016952598C126322002 @default.
• W2016952598 hasConceptScore W2016952598C134018914 @default.
• W2016952598 hasConceptScore W2016952598C159654299 @default.
• W2016952598 hasConceptScore W2016952598C170493617 @default.
• W2016952598 hasConceptScore W2016952598C185592680 @default.
• W2016952598 hasConceptScore W2016952598C203014093 @default.
• W2016952598 hasConceptScore W2016952598C2775960820 @default.
• W2016952598 hasConceptScore W2016952598C2780689927 @default.
• W2016952598 hasConceptScore W2016952598C2780898057 @default.
• W2016952598 hasConceptScore W2016952598C71924100 @default.
• W2016952598 hasConceptScore W2016952598C86803240 @default.
• W2016952598 hasConceptScore W2016952598C8891405 @default.
• W2016952598 hasIssue "9" @default.
• W2016952598 hasLocation W20169525981 @default.
• W2016952598 hasLocation W20169525982 @default.
• W2016952598 hasOpenAccess W2016952598 @default.
• W2016952598 hasPrimaryLocation W20169525981 @default.
• W2016952598 hasRelatedWork W1981791036 @default.
• W2016952598 hasRelatedWork W1985174655 @default.
• W2016952598 hasRelatedWork W1997355536 @default.
• W2016952598 hasRelatedWork W2001956022 @default.
• W2016952598 hasRelatedWork W2028080517 @default.
• W2016952598 hasRelatedWork W2031654731 @default.
• W2016952598 hasRelatedWork W2041273250 @default.
• W2016952598 hasRelatedWork W2126532023 @default.
• W2016952598 hasRelatedWork W2128683464 @default.
• W2016952598 hasRelatedWork W3080634917 @default.
• W2016952598 hasVolume "4" @default.
• W2016952598 isParatext "false" @default.
• W2016952598 isRetracted "false" @default.

• next